Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Precision Medicine
Fierce Pharma
Roche touts Tecentriq biomarker win in bladder cancer
Roche's biomarker-driven adjuvant approach differs from the perioperative route taken by AstraZeneca and a Pfizer-Astellas-Merck trio.
Angus Liu
Aug 18, 2025 4:17pm
Arialys presents promising data for IgG1 antibody treatment
Jun 20, 2025 5:02am
Bayer boosts precision oncology efforts with multiyear AI deal
Apr 23, 2025 12:55pm
Eye disease biotech looks to clinical trials with $93M series B
Mar 25, 2025 8:00am
Prothena promotes one exec while another leaves—Chutes & Ladders
Oct 4, 2024 8:00am
FDA OKs Illumina's tumor gene test as a companion diagnostic
Aug 28, 2024 12:00pm
